LBT Innovations Limited researches and develops clinical and diagnostic technologies for the healthcare and laboratory supply markets in Australia, Switzerland, and the United States. It offers PREVI Isola, an automated streaking and inoculation system that provides automation of culture plate streaking; and automated plate assessment system, a platform technology for the automation of culture-plate screening and interpretation. The company also develops Woundvue, a proposed automation solution to assist in the management of chronic wounds. It has a licence agreement with bioMérieux, a diagnostics company to manufacture and market PREVI Isola. The company was founded in 2004 and is based in Adelaide, Australia.
lbt innovations ltd
(LSM:Berlin Stock Exchange)
300 Flinders Street
Adelaide, SA 5000
Phone: 61 8 8227 1555
Fax: 61 8 8223 1775www.lbtinnovations.com
|No competitor information is available for LSM.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact LBT INNOVATIONS LTD, please visit www.lbtinnovations.com. Company data is provided by Capital IQ. Please use this form to report any data issues.